Korro Bio, Inc. (Korro) (Nasdaq: KRRO), a clinical-stage biopharmaceutical company focused on developing a new class of genetic medicines based on editing RNA for both rare and highly prevalent ...

Despite not meeting the endpoint, subjects have experienced a meaningful improvement in RBC transfusion independence.

Following the FDA ODD, European designation underscores ICT01’s potential as a ...

NanoViricides, Inc., a publicly traded company (NYSE Amer.: NNVC ) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

Protalix BioTherapeutics, Inc. (NYSE American: PLX), a biopharmaceutical company focused on the development, production ...

Medicines derived from living cells — biologics — are some of the most expensive medicines in America. What keeps prices ...

CorestemChemon (KOSDAQ: 166480) is a full-service preclinical CRO with over two decades of experience in GLP-based toxicology ...

UK MHRA approves ALK’s EURneffy, a needle-free anaphylaxis treatment of adults and children in UK: Hørsholm, Denmark Monday, July 21, 2025, 14:00 Hrs [IST] ALK, a global specia ...

EU citizen arrivals to raise more 'own resources' for the EU budget. View on euronews ...

Strategic partnership to deliver transcriptomics-powered, organoid-based preclinical testing for high-impact drug discovery  SEOUL, South Korea, July 20, ...